Oxygen-metabolism indices in glioblastoma MRI are primarily maps of blood flow, not metabolic activity. Clinicians should use these indices only in conjunction with a full perfusion panel, as the signal is heavily skewed by vascularity and tumor-induced hemodynamic changes in peritumoral tissue.
A study shows that DSC-MRI oxygen-metabolism maps in glioblastoma are 92% driven by blood flow, not oxygen extraction. Learn how to interpret these results.
No, it is not a direct measure. The index is a mathematical composite heavily dominated by blood flow, which accounts for over 92% of the signal. It should be interpreted as a hemodynamic indicator rather than a direct measurement of how much oxygen the tumor cells are consuming.
The maps change because the tumor's expansion alters the blood flow dynamics in the surrounding brain tissue, known as the peritumoral region. This physical pressure changes how blood moves through the area, which the MRI software incorrectly interprets as a change in oxygen metabolism.
You should use these maps only as part of a larger perfusion panel. Never rely on them as an independent source of metabolic evidence. Always cross-reference the index with primary blood flow and blood volume maps to confirm whether a high signal is due to vascularity or metabolic demand.
This study specifically examined untreated glioblastomas. While the underlying physics of DSC-MRI is universal, the specific contribution of blood flow versus oxygen extraction may vary depending on the tumor type, grade, and vascular architecture. Further research is needed to confirm these ratios in other tumor pathologies.